Open Access

Ethyl 2‑anilino‑4‑oxo‑4,5‑dihydrofuran‑3‑carboxylate exhibits anti‑proliferative activity and induces apoptosis in promyelocytic leukemia HL‑60 cells

  • Authors:
    • An‑Cheng Huang
    • Chen‑Sheng Lin
    • Jin‑Cherng Lien
    • Hsueh‑Chou Lai
    • Wei‑Hua Lin
    • Cheng‑Wen Lin
  • View Affiliations

  • Published online on: January 23, 2020     https://doi.org/10.3892/ol.2020.11342
  • Pages: 2397-2403
  • Copyright: © Huang et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Furoquinolone and its derivatives exhibit antimicrobial, anti‑allergic, anti‑inflammatory and anticancer properties. The present study investigated the anti‑tumor activity of synthesized intermediates of furoquinolone in human promyelocytic leukemia HL‑60 cells. The biological effects of the active compound ethyl 2‑anilino‑4‑oxo‑4,5‑​dihydrofuran‑3‑carboxylate (compound 131) were examined in HL‑60 cells. The following properties were analyzed: Cell survival, cell cycle profile, caspase‑3 activity, Bax and Bcl‑2 expression, the amount of intracellular Ca2+, the number of reactive oxygen species (ROS) and the mitochondrial membrane potential. Compound 131 (50% cytotoxic concentration, 23.5 µM) significantly reduced the proliferation of HL‑60 cells and was revealed to induce apoptosis in HL‑60 cells in a concentration‑dependent manner. Moreover, this was associated with the activation of caspase‑3, upregulation of Bax, an increase in intracellular Ca2+ and ROS production, and a decrease in mitochondrial membrane potential and Bcl‑2 expression levels. Compound 131, a novel 4,5‑dihydrofuran‑3‑carboxylate, induced apoptosis in HL‑60 cells via the increase of intracellular Ca2+ and ROS to alter the mitochondrial membrane potential and the protein level of Bax and Bcl‑2, as well as activating caspase‑3. The results of the current study indicate that compound 131 may represent a promising compound for the development of anti‑leukemia therapeutics.
View Figures
View References

Related Articles

Journal Cover

March-2020
Volume 19 Issue 3

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Huang AC, Lin CS, Lien JC, Lai HC, Lin WH and Lin CW: Ethyl 2‑anilino‑4‑oxo‑4,5‑dihydrofuran‑3‑carboxylate exhibits anti‑proliferative activity and induces apoptosis in promyelocytic leukemia HL‑60 cells. Oncol Lett 19: 2397-2403, 2020.
APA
Huang, A., Lin, C., Lien, J., Lai, H., Lin, W., & Lin, C. (2020). Ethyl 2‑anilino‑4‑oxo‑4,5‑dihydrofuran‑3‑carboxylate exhibits anti‑proliferative activity and induces apoptosis in promyelocytic leukemia HL‑60 cells. Oncology Letters, 19, 2397-2403. https://doi.org/10.3892/ol.2020.11342
MLA
Huang, A., Lin, C., Lien, J., Lai, H., Lin, W., Lin, C."Ethyl 2‑anilino‑4‑oxo‑4,5‑dihydrofuran‑3‑carboxylate exhibits anti‑proliferative activity and induces apoptosis in promyelocytic leukemia HL‑60 cells". Oncology Letters 19.3 (2020): 2397-2403.
Chicago
Huang, A., Lin, C., Lien, J., Lai, H., Lin, W., Lin, C."Ethyl 2‑anilino‑4‑oxo‑4,5‑dihydrofuran‑3‑carboxylate exhibits anti‑proliferative activity and induces apoptosis in promyelocytic leukemia HL‑60 cells". Oncology Letters 19, no. 3 (2020): 2397-2403. https://doi.org/10.3892/ol.2020.11342